Next Article in Journal
Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy
Next Article in Special Issue
A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness
Previous Article in Journal
Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessArticle

The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage

Department of Tumorimmunology, Radboud Institute for Molecular Life Sciences, RadboudUMC, Geert Grooteplein 28, 6525GA Nijmegen, The Netherlands
Cancers 2018, 10(11), 431; https://doi.org/10.3390/cancers10110431
Received: 9 October 2018 / Revised: 2 November 2018 / Accepted: 9 November 2018 / Published: 12 November 2018
(This article belongs to the Special Issue Advances in Cancer Stem Cell Research)
  |  
PDF [4701 KB, uploaded 12 November 2018]
  |  

Abstract

Current treatments for oligodendrogliomas are powerful but have a negative impact on the rest of the body. The bone marrow is damaged by the chemotherapeutics, but other parts of the body are also affected. In this paper, the current treatment method and its collateral damage is described. Therefore, therapies are needed that are more effective against the tumor while having less negative effects on the patient’s quality of life. Some potential therapies include optimal removal of the tumor by fluorescent-guided surgery (FGS), intraoperative desorption electrospray ionization-mass spectrometry (DESI-MS), better monitoring of the effects of therapy by pseudo-coloring shades of gray of MRI pictures, and using recent data from RNA sequencing of single cells and immunotherapy. These are all open new ways of treating this tumor. The RNA sequencing of single tumor cells unravels specific tumor antigens present in the differentiation status of the cancer cell. Stem cell antigens were expressed in dividing cells, while hypoxia inducible factor-α (HIF-1α) is expressed in all tumor cells. Cancer stem cell antigens can be loaded on dendritic cells to induce cytotoxic T-cells directed to cancer stem cells. These recent discoveries suggest a better quality of life with the same overall survival. View Full-Text
Keywords: oligodendroglioma; single-cell RNA sequencing; pseudo-coloring MRI; Dendritic cell vaccination; fluorescence-guided surgery; mass spectrometry surgery; quality of life oligodendroglioma; single-cell RNA sequencing; pseudo-coloring MRI; Dendritic cell vaccination; fluorescence-guided surgery; mass spectrometry surgery; quality of life
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Torensma, R. The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage. Cancers 2018, 10, 431.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top